Amzeal News/10224715

IMPRESS!® Dietary Supplement for Men Redefines Male Enhancement, Choosing Potent FenuSterols® from Sabinsa

MaxLabs US, maker of IMPRESS!® Dietary Supplement for Men, officially announces Sabinsa as a key supplier partner. Their FenuSterols® brings the proven impact of steroidal saponins to this new, high-potency blend that redefines male enhancement supplements. FenuSterols® significantly bolsters the physical performance properties of this U.S. Pat. Pend. formula that's the first male enhancement offering to also integrate the energy and clarity of nootropics and exotic natural anxiolytics.

WASHINGTON, Mich. - April 7, 2017 - Amzeal -- Charles Kraft, R.N., MaxLabs V.P. Functional Health, relates:

Our Patent Pending formulation provides high-potency nutritional support of three key needs that impact men's overall sexual experience by including time-tested, heavily-researched ingredients from leading suppliers. Analysis concluded a phytoextract rich in furostanol saponins (steroidal saponins) would be an ideal choice for IMPRESS!®.

Numerous studies underscore these key constituents' support of increased strength and healthy testosterone levels – Properties that have made Fenugreek one of the most frequently specified ingredients in OTC sexual performance formulas. Not every Fenugreek extract is created equal, nor aligns with our goal of providing consumers Innovation, Quality & Value.

When it came to selecting the source of steroidal saponins for IMPRESS!® there was really just one "premium" choice. Sabinsa's vast R&D and modern manufacturing capabilities permit them to produce a highly-standardized extract with an incredible 50% steroidal saponins. Providing men the highest-potency ingredients is a key aspect of our value proposition, as illustrated by lab analysis comparing FenuSterols® to the competition that reveals major advantages with: 23-times the Diosgenin, 150-times the quantity of 4-HIL and overall, twice the quantity of Steroidal Saponins.[1]
We couldn't be happier to bring on a research-centric supplier partner like Sabinsa. Addition of FenuSterols® is yet another reason IMPRESS!® will be a safe, enjoyable addition to men's lives that redefines male enhancement.

Shaheen Majeed, Marketing Director, Sabinsa Corporation, states:

We are excited that Fenusterols® has found a place in IMPRESS! It will synergize well with the other actives in the formulation with important functions of promoting general health, improving fertility, testosterone and muscle mass! Fenusterols® is the saponin rich fraction obtained from Fenugreek seeds, which contain saponins in the form of furostanol saponins. In a published clinical study, a preparation rich in furostanol saponins was shown to possess immunostimulating and luteinizing hormone releasing properties. The furostanols preparation also increased testosterone levels and Spermatogenesis.

About MaxLabs US

MaxLabs US designs and markets premium quality nutraceutical products for human use. With a business model built on Innovation, Quality & Value, the company is led by a core team possessing over 75 years of collective experience in business leadership, healthcare and medical devices. The new company is focused on quickly establishing dominance over direct competitors and expanding its portfolio based on market needs. Quality assurance, testing, manufacturing and packaging of MaxLabs US products are proudly U.S.-based. MaxLabs US is headquartered in Washington, MI USA. For more information, see www.IMPRESS1600.com.
About Sabinsa Corporation

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 28 years, Sabinsa has brought to market more than 100 standardized botanical extracts, and privately funded clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 full-time scientists conducting ongoing research in the United States & India, Sabinsa and parent company Sami Labs Ltd. continue to develop, patent and manufacture phytonutrients for the world market, with ingredients that are both Halal and Kosher. For more information, visit www.sabinsa.com.

These statements have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, cure, treat or prevent any disease.

1. Data on file. Sami Labs for Sabinsa Corporation.

Contacts

MaxLabs US
Charles Kraft, R.N.
SABINSA PRESS CONTACT
SHAHEEN MAJEED
MARKETING DIRECTOR
801-465-8400
shaheen@sabinsa.com

Contact
Charles Kraft, R.N.
***@maxlabsus.com


Source: MaxLabs US

Show All News